Greenpharma listed on thegentlemen leak site

• Ransomware group: thegentlemen
• Country: Brazil
• Sector: Healthcare
• Announcement date: April 19, 2026

Brazilian pharmaceutical manufacturer Greenpharma listed by thegentlemen

The Brazilian pharmaceutical manufacturer Greenpharma has been listed on a leak site by the threat actor group known as thegentlemen. This announcement follows an alleged cyber incident targeting the organization, marking a potential significant breach for the healthcare sector in the region.

Details of the alleged cyber incident

According to the announcement made by thegentlemen on April 19, 2026, the group claims to have gained access to the institution's data. The post suggests that the organization experienced a cyber incident on April 15, 2026, several days prior to the public listing on the leak site.

Ransomware groups often utilize leak sites to pressure victims into paying ransoms through a tactic known as double extortion. In such scenarios, attackers not only encrypt an organization's internal systems to disrupt operations but also steal sensitive data, threatening to release it publicly if their demands are not met. This method increases the leverage held by the threat actors, as the threat of a data leak can cause significant reputational and legal damage even if the company can restore its systems from backups.

Information regarding the leaked data

Regarding the specifics of the breach, the group has not provided any screenshots or detailed information regarding the content of the allegedly leaked data. Furthermore, there is no information available concerning the total size of the data or the specific number of files involved. The listing does not include any information regarding a ransom demand.

The listing names no specific data types that have been compromised.

The organization profile

Greenpharma Química & Farmaceutica is a Brazilian pharmaceutical manufacturer that was founded in 1989. The company is involved in the production of generic and over-the-counter (OTC) medicines. Furthermore, the company operates its own ANVISA-accredited pharmaceutical equivalence laboratory and is responsible for distributing its products to various pharmacies and hospitals throughout Brazil.

Potential impact and assessment

This incident may pose risks to the institution's operational processes and commercial reputation. Because the organization operates within the highly regulated healthcare sector, the alleged data breach may lead to secondary risks such as identity theft or targeted phishing attacks for employees and customers. Additionally, the institution's supply chain partners may also be indirectly affected by this situation.

From a legal perspective, it is likely that legal processes regarding data protection under Brazil's LGPD legislation could be triggered. Organizations facing such threats often must navigate complex regulatory requirements to report breaches and protect consumer rights.

Public information about the thegentlemen group is limited; therefore, a definitive assessment of the group's methods and motivations cannot be made. In general, when organizations in the healthcare and pharmaceutical sectors face such threats, common defensive steps include implementing robust multi-factor authentication, maintaining offline backups, and conducting regular security awareness training to prevent phishing-based initial access.